Current status and future perspectives of liquid biopsy in non-small cell lung cancer

Current status and future perspectives of liquid biopsy in non-small cell lung cancer

With advances in target therapy, molecular analysis of tumors is routinely required for treatment decisions in patients with advanced non-small cell lung cancer (NSCLC). Liquid biopsy refers to the sampling and analysis of circulating cell-free tumor DNA (ctDNA) in various body fluids, primarily blo...

Full description

Bibliographic Details
Main Authors: Sunhee Chang, Jae Young Hur, Yoon-La Choi, Chang Hun Lee, Wan Seop Kim
Format: Article
Language:English
Published: Korean Society of Pathologists & the Korean Society for Cytopathology 2020-05-01
Series:Journal of Pathology and Translational Medicine
Subjects:
carcinoma, non-small cell lung cancer
liquid biopsy
circulating tumor dna
epidermal growth factor receptor
biomarkers
Online Access:http://www.jpatholtm.org/upload/pdf/jptm-2020-02-27.pdf

Similar Items

Similar Items